{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:25:39Z","timestamp":1772321139394,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Pharmaceutical Spain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lungcan.2025.108763","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:51:56Z","timestamp":1758765116000},"page":"108763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-198X","authenticated-orcid":false,"given":"Dolores","family":"Isla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Zugazagoitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-7519","authenticated-orcid":false,"given":"Edurne","family":"Arriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Garc\u00eda-Campelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-1936","authenticated-orcid":false,"given":"Cristina","family":"Mart\u00ed Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Diz-Ta\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"L\u00f3pez-Brea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-7773","authenticated-orcid":false,"given":"Alberto Luis","family":"Moreno-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0742-1209","authenticated-orcid":false,"given":"Luis","family":"Le\u00f3n-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Oram\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-9616","authenticated-orcid":false,"given":"Vanesa","family":"Guti\u00e9rrez-Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Majem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Alvarez-Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartomeu","family":"Massut\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8699-5800","authenticated-orcid":false,"given":"Jos\u00e9-Luis","family":"F\u00edrvida-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Valdivia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gonz\u00e1lez-Cordero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zafra-Poves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"D\u00f3mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0013-4538","authenticated-orcid":false,"given":"Francisco Javier","family":"Garcia-Navalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-9030","authenticated-orcid":false,"given":"Oscar","family":"Juan-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rivas-Corredor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Eugenia","family":"Olmedo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Palmero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-4710","authenticated-orcid":false,"given":"Rafael","family":"L\u00f3pez-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Carcereny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Lechuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2383-9856","authenticated-orcid":false,"given":"Marta","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1656-4019","authenticated-orcid":false,"given":"\u00c1ngel","family":"Callejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108763_b0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.21.01881","article-title":"Extensive-stage small-cell lung cancer: first-line and second-line treatment options","volume":"40","author":"Zugazagoitia","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0010","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.23.01435","article-title":"Systemic therapy for small-cell lung cancer: ASCO-Ontario health (Cancer care ontario) guideline","volume":"41","author":"Khurshid","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0015","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"IMpower133 study group, first-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108763_b0020","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"CASPIAN investigators, Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"issue":"2023","key":"10.1016\/j.lungcan.2025.108763_b0025","first-page":"2679","article-title":"SEOM-GECP clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)","volume":"25","author":"Garcia-Campelo","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0030","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.3390\/curroncol30070465","article-title":"Canadian consensus recommendations on the management of extensive-stage small-cell lung cancer","volume":"30","author":"Melosky","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100408","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN","volume":"7","author":"Paz-Ares","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2025.108763_b0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1078-0432.CCR-23-1689","article-title":"Durvalumab +\/- tremelimumab + platinum-etoposide in extensive-stage small cell lung cancer (CASPIAN): outcomes by PD-L1 expression and tissue tumor mutational burden","volume":"30","author":"Paz-Ares","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108763_b0045","first-page":"35","article-title":"Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer","volume":"7","author":"Minami","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108763_b0050","first-page":"1585","article-title":"Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study, Transl. Lung","volume":"13","author":"Misawa","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108763_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1002385","article-title":"Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer","volume":"12","author":"Rittberg","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.lungcan.2025.108763_b0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life","author":"Bergman","year":"1994","journal-title":"Eur. J. Cancer 30A"},{"key":"10.1016\/j.lungcan.2025.108763_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0075","first-page":"805","article-title":"Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status, Thorac","volume":"14","author":"Mamesaya","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2025.108763_b0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000524476","article-title":"Dose modification of etoposide plus platinum in elderly patients with extensive-disease small-cell lung cancer","volume":"100","author":"Kim","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.lungcan.2025.108763_b0085","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1200\/JCO.2024.42.16_suppl.8101","article-title":"Safety and efficacy of durvalumab plus carboplatin and etoposide for patients with previously untreated extensive-stage small-cell lung cancer (ES-SCLC) with a poor performance status: the results from phase II single-arm study (NEJ045A study)","volume":"42","author":"Saida","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0090","doi-asserted-by":"crossref","first-page":"S1652","DOI":"10.1016\/j.annonc.2024.10.695","article-title":"662P comparison of atezolizumab\/etoposide\/platinum and durvalumab\/etoposide\/platinum for extensive-stage small cell lung cancer in Japan: a multicenter retrospective observational study","volume":"35","author":"Sakashita","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2025.108763_b0095","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.21873\/anticanres.17132","article-title":"Comparison of real-world efficacy and safety of atezolizumab and durvalumab in combination with chemotherapy for first-line treatment of extensive-stage small-cell lung cancer","volume":"44","author":"Igata","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2025.108763_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107999","article-title":"Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer","volume":"198","author":"Vince","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108763_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114277","article-title":"Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting","volume":"210","author":"Falchero","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108763_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107379","article-title":"Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: results of the IFCT-1905 CLINATEZO real-world study","volume":"185","author":"Falchero","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108763_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108499","article-title":"Clinical characteristics and management of long survivors in extensive stage small cell lung cancer","volume":"202","author":"Gobbini","year":"2025","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:45:32Z","timestamp":1762490732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"alternative-id":["S0169500225006555"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108763","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108763"}}